|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 11/00 | |||
| C07K 16/22 | |||
| A61K 45/06 |
| (11) | Number of the document | 2083863 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07867199.7 |
| Date of filing the European patent application | 2007-10-03 | |
| (97) | Date of publication of the European application | 2009-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/021234 |
| Date | 2007-10-03 |
| (87) | Number | WO 2008/060371 |
| Date | 2008-05-22 |
| (30) | Number | Date | Country code |
| 827933 P | 2006-10-03 | US |
| (72) |
STREISAND, James B., US
ROBERTS, Jesse D. Jr., US
|
| (73) |
Genzyme Corporation,
500 Kendall Street, Cambridge, MA 02142,
US
The General Hospital Corporation, Massachusetts General Hospital 55 Fruit Street, Boston, MA 02114, US |
| (54) | ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |